These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 38692466)

  • 1. Macrophages and tumor-associated macrophages in the senescent microenvironment: From immunosuppressive TME to targeted tumor therapy.
    Du M; Sun L; Guo J; Lv H
    Pharmacol Res; 2024 Jun; 204():107198. PubMed ID: 38692466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Associated Senescent Macrophages, Their Markers, and Their Role in Tumor Microenvironment.
    Pukhalskaia TV; Yurakova TR; Bogdanova DA; Demidov ON
    Biochemistry (Mosc); 2024 May; 89(5):839-852. PubMed ID: 38880645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular senescence and SASP in tumor progression and therapeutic opportunities.
    Dong Z; Luo Y; Yuan Z; Tian Y; Jin T; Xu F
    Mol Cancer; 2024 Aug; 23(1):181. PubMed ID: 39217404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment.
    Zhang F; Guo J; Yu S; Zheng Y; Duan M; Zhao L; Wang Y; Yang Z; Jiang X
    Cancer Commun (Lond); 2024 Sep; 44(9):929-966. PubMed ID: 38997794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of tumor-associated macrophages in tumor immune evasion.
    Huang R; Kang T; Chen S
    J Cancer Res Clin Oncol; 2024 May; 150(5):238. PubMed ID: 38713256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell senescence-induced macrophage CD73 expression is a critical metabolic immune checkpoint in the aging tumor microenvironment.
    Deng Y; Chen Q; Yang X; Sun Y; Zhang B; Wei W; Deng S; Meng J; Hu Y; Wang Y; Zhang Z; Wen L; Huang F; Wan C; Yang K
    Theranostics; 2024; 14(3):1224-1240. PubMed ID: 38323313
    [No Abstract]   [Full Text] [Related]  

  • 7. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies.
    D'Ambrosio M; Gil J
    Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review).
    Su P; Li O; Ke K; Jiang Z; Wu J; Wang Y; Mou Y; Jin W
    Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38695252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting tumor-associated macrophages to reverse antitumor drug resistance.
    Li S; Sheng J; Zhang D; Qin H
    Aging (Albany NY); 2024 May; 16(11):10165-10196. PubMed ID: 38787372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.
    Zhang SY; Song XY; Li Y; Ye LL; Zhou Q; Yang WB
    Pharmacol Res; 2020 Nov; 161():105111. PubMed ID: 33065284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting senescence-associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes.
    Xiong J; Dong L; Lv Q; Yin Y; Zhao J; Ke Y; Wang S; Zhang W; Wu M
    Clin Transl Med; 2024 Sep; 14(9):e1772. PubMed ID: 39270064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications.
    Zhao B; Wu B; Feng N; Zhang X; Zhang X; Wei Y; Zhang W
    J Hematol Oncol; 2023 Mar; 16(1):28. PubMed ID: 36945046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting tumor-associated macrophages as an antitumor strategy.
    Cheng N; Bai X; Shu Y; Ahmad O; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire.
    Malik S; Sureka N; Ahuja S; Aden D; Zaheer S; Zaheer S
    Cell Biol Int; 2024 Oct; 48(10):1406-1449. PubMed ID: 39054741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoding the spatiotemporal heterogeneity of tumor-associated macrophages.
    Chu X; Tian Y; Lv C
    Mol Cancer; 2024 Jul; 23(1):150. PubMed ID: 39068459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact and potential value of immunosenescence on solid gastrointestinal tumors.
    Zhang T; Wen R; Fan H; Yu Y; Jia H; Peng Z; Zhou L; Yu G; Zhang W
    Front Immunol; 2024; 15():1375730. PubMed ID: 39007138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
    Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
    Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy.
    Toledo B; Zhu Chen L; Paniagua-Sancho M; Marchal JA; Perán M; Giovannetti E
    J Hematol Oncol; 2024 Jun; 17(1):44. PubMed ID: 38863020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic studies of tumor-associated macrophage immunotherapy.
    Cao J; Liu C
    Front Immunol; 2024; 15():1476565. PubMed ID: 39403370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.